Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates. [electronic resource]
- Oncotarget Jul 2017
- 44141-44158 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.17390 doi
Adult Aged Aged, 80 and over Amino Acid Sequence Antigens, Neoplasm--immunology Biomarkers, Tumor Female Glioblastoma--diagnosis Humans Male Middle Aged Neoplasm Grading Prognosis Proteome--immunology Proteomics--methods Reproducibility of Results Single-Domain Antibodies--chemistry